Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

(2011) Ann Mosegaard Bak et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia

(2011) Bernardo Nuche-Berenguer et al.   JOURNAL OF ENDOCRINOLOGY

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

(2010) Bernardo Nuche-Berenguer et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

(2009) C. Sanz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

(2009) Bernardo Nuche-Berenguer et al.   CALCIFIED TISSUE INTERNATIONAL

Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats

(2009) Jason G. Barrera et al.   DIABETES

The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9–36)a in an isolated rat heart

(2009) Alvilde Ossum et al.   PHARMACOLOGICAL RESEARCH

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states

(2009) Bernardo Nuche-Berenguer et al.   REGULATORY PEPTIDES

Induction and Reversibility of Insulin Resistance in Rats Exposed to ExogenousD-Fructose

(2008) J. Cancelas et al.   HORMONE AND METABOLIC RESEARCH

Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state

(2008) Luis Arnés et al.   REGULATORY PEPTIDES